Here’s what you need to know:
1. The award will recognize innovative research done in Takeda Pharmaceutical’s four areas of focus: gastroenterology, oncology, neuroscience and regenerative medicine.
2. The New York Academy of Sciences will administer the award on behalf of Takeda Pharmaceutical, including the solicitation of nominations and overseeing all selections.
3. The society will announce two $200,000 awards each year; one award will go to an early-career scientist and one award will go to a well-established scientist.
The nomination period for the inaugural prizes is slated to open March 2017. These winners will be honored in November 2017.
More articles on gastroenterology and endoscopy:
AGA, NACCME develop 3 regional educational programs about IBD: 3 notes
Clinical Genomics’ circulating tumor DNA blood test proves effective for CRC recurrence detection: 3 notes
Takeda Pharmaceuticals, Koneksa Health to introduce biosensors, wearable technology into clinical studies: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
